These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33455481)

  • 1. Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD.
    Sabbagh MN; Pope E; Cordes L; Shi J; DeCourt B
    Expert Opin Investig Drugs; 2021 Jan; 30(1):39-44. PubMed ID: 33455481
    [No Abstract]   [Full Text] [Related]  

  • 2. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases.
    Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
    PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
    Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
    Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
    Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
    J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
    Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.
    Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N
    Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Chiba-Falek O; Gottschalk WK; Lutz MW
    Alzheimers Dement; 2018 May; 14(5):692-698. PubMed ID: 29524426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease biomarkers.
    Kulminski AM; Jain-Washburn E; Loiko E; Loika Y; Feng F; Culminskaya I;
    Aging (Albany NY); 2022 Nov; 14(24):9782-9804. PubMed ID: 36399096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.
    Yu CE; Seltman H; Peskind ER; Galloway N; Zhou PX; Rosenthal E; Wijsman EM; Tsuang DW; Devlin B; Schellenberg GD
    Genomics; 2007 Jun; 89(6):655-65. PubMed ID: 17434289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    Mise A; Yoshino Y; Yamazaki K; Ozaki Y; Sao T; Yoshida T; Mori T; Mori Y; Ochi S; Iga JI; Ueno SI
    J Alzheimers Dis; 2017; 60(3):1107-1117. PubMed ID: 28984592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.
    Bakeberg MC; Hoes ME; Gorecki AM; Theunissen F; Pfaff AL; Kenna JE; Plunkett K; Kõks S; Akkari PA; Mastaglia FL; Anderton RS
    Sci Rep; 2021 Mar; 11(1):6363. PubMed ID: 33737565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE, TOMM40, and sex interactions on neural network connectivity.
    Li T; Pappas C; Le ST; Wang Q; Klinedinst BS; Larsen BA; Pollpeter A; Lee LY; Lutz MW; Gottschalk WK; Swerdlow RH; Nho K; Willette AA
    Neurobiol Aging; 2022 Jan; 109():158-165. PubMed ID: 34740077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.